# Mass Balance Clinical Trial With TEV-56286

> **NCT06627231** · PHASE1 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** TEV-56286
- **DRUG:** [14C]-TEV-56286

## Key facts

- **NCT ID:** NCT06627231
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-08
- **Primary completion:** 2024-11-29
- **Final completion:** 2024-11-29
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06627231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06627231, "Mass Balance Clinical Trial With TEV-56286". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06627231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*